POET Technologies: How a $400M Capital Injection and a Class-Action Lawsuit Are Reshaping the AI Photonics Play

The story of POET Technologies this spring is one of staggering contrasts. On one hand, the company locked down $400 million in fresh equity through a single institutional placement at $21 a share. On the other, a key customer — Celestial AI, now owned by Marvell Semiconductor — tore up all its purchase orders, triggering a 47% one-day crash and a class-action lawsuit that has yet to run its course. The stock closed last week at $12.29, some 37% below that $21 fundraising price, leaving investors to weigh a bulging war chest against a badly damaged credibility.

The Celestial AI fallout and the gathering legal storm

The rupture with Celestial AI was abrupt and public. On April 23, Marvell informed POET in writing that it was cancelling all outstanding orders, citing the disclosure of confidential information about order volumes and delivery dates by a POET executive. That single event sliced nearly half the stock’s value in a day and set the stage for a securities class action now targeting the company, its CEO and CFO. The complaint — filed on behalf of investors who bought POET shares between April 1 and April 27, 2026 — alleges misleading statements about business relationships and the company’s tax status.

At the heart of the tax accusation is a potential reclassification of POET as a Passive Foreign Investment Company (PFIC), a designation that would impose severe tax penalties on US shareholders. Multiple law firms have already issued reminders that the lead?plaintiff deadline falls on June 29. That date now looms as a key risk catalyst.

Lumilens provides a counterweight — but only on paper

In the same turbulent month, POET announced its first production order from Lumilens: $50 million for optical engines based on the EOI platform. The deal is framed as the initial phase of a relationship that could stretch five years. Yet the total confirmed order book remains modest, and management has indicated that meaningful deliveries are not expected before 2027. For a company with a market capitalization still above $2 billion, the revenue gap is cavernous.

Should investors sell immediately? Or is it worth buying POET Technologies?

First?quarter 2026 results underscore the challenge. Revenue hit $503,389 — more than double the year?ago quarter — but the net loss widened to $12.3 million, or $0.08 per share. That puts the price?to?sales ratio at roughly 1,500, a multiple that leaves no margin for error.

$400 million in cash, but at a cost

The capital raise completed on May 18 was a lifeline of unusual size. A single institutional investor took down roughly 19 million new shares at $21 each, plus an equal number of warrants with a strike price of $26.15. The gross proceeds of $400 million are earmarked for production infrastructure, R&D and operations. POET plans to roughly decuple its wafer and optical?engine capacity by 2027, with a particular focus on ramping 800G and 1.6T product lines.

The flip side is heavy dilution. Existing shareholders saw their stakes trimmed, and the $21 placement price itself has become a psychological resistance level. The chart shows that the stock has not been able to reclaim it since the capital raise closed.

Trading intensity tells a story of its own

The shares have been anything but quiet. On the Friday alone, 30.9 million shares changed hands. On May 18 and 19, daily volume exceeded 75 million — a level that suggests active repositioning by both bulls and bears, not orderly accumulation. The stock touched an intraday low of $11.50 on Friday before settling at $12.29, down 7.3% on the day and roughly 16% below the week’s high of $14.59 set on May 22.

Technical support now lies at that Friday low of $11.50. Resistance is first seen near $13.55, the two?day high from earlier in the week. Longer?term moving averages — the 50?day at $9.49 and the 200?day at $7.03 — sit well below the current price, suggesting the medium?term uptrend remains intact despite the recent pullback.

POET Technologies at a turning point? This analysis reveals what investors need to know now.

Analyst expectations have been slashed

The median analyst price target has fallen to $8.20, implying further downside from current levels. Earnings forecasts have also been revised sharply lower: consensus has swung from a profit of $5.66 million for 2026 to a loss of $8.90 million. The departure from the $21 placement price and the warrants’ $26.15 strike now mark the two most prominent chart resistance zones — a reminder of how far the stock has retreated from the heights of early April, when it traded above $20.

Meanwhile, the company has moved to shore up operations. Sandeep Kumar, a Silicon Labs veteran with 18 years of experience, was appointed chief operating officer to oversee the Malaysian production ramp. He received 410,397 restricted stock units vesting over three years.

With the class?action lead?plaintiff deadline set for June 29, the next few weeks will be dominated by legal developments. POET has a clear production roadmap and ample capital, but it has also lost a major customer’s trust and faces a shareholder suit that could drag on for months. For the stock to close the gap with its $21 floor, the narrative will need to shift from damage control to delivery.

Ad

POET Technologies Stock: New Analysis - 30 May

Fresh POET Technologies information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated POET Technologies analysis...

en | CA73044W3021 | POET | boerse | 69449574 |